These results are in line with previous reports indicating that androgen deprivation therapy (ADT) increases cAMP/PKA/CREB signaling, and implicated this axis with PCa transition to neuroendocrine disease [40], associated with treatment resistance and disease progression [40]. This evidence concerns the gene CREB1 and posterior cortical atrophy.